허주영 교수
#림프망내계병리
|
학력
1995 .03 ~ 1997 .02서울대학교 의학 박사
1975 .03 ~ 1981 .02서울대학교 의학 학사
1975 .03 ~ 1981 .02서울대학교 의학 학사
경력
2005 .03 ~ 현재울산의대 서울아산병원 병리과, 교수
2000 .03 ~ 2005 .02울산의대 서울아산병원 병리과, 부교수
1996 .03 ~ 2000 .02울산의대 서울아산병원 병리과, 조교수
1994 .03 ~ 1996 .02울산의대 서울아산병원 병리과, 전임강사
1993 .03 ~ 1994 .04서울대학교병원 전임의
1988 .05 ~ 1990 .02미국 성요셉병원 겸임교수
1986 .07 ~ 1988 .04미국 뉴저지주립대 전임의
1982 .07 ~ 1986 .06미국 성바르나병원 전공의
1981 .03 ~ 1982 .02서울대병원 수련의
2000 .03 ~ 2005 .02울산의대 서울아산병원 병리과, 부교수
1996 .03 ~ 2000 .02울산의대 서울아산병원 병리과, 조교수
1994 .03 ~ 1996 .02울산의대 서울아산병원 병리과, 전임강사
1993 .03 ~ 1994 .04서울대학교병원 전임의
1988 .05 ~ 1990 .02미국 성요셉병원 겸임교수
1986 .07 ~ 1988 .04미국 뉴저지주립대 전임의
1982 .07 ~ 1986 .06미국 성바르나병원 전공의
1981 .03 ~ 1982 .02서울대병원 수련의
논문
Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL).
Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma.
Blastic plasmacytoid dendritic cell neoplasm in the CSF.
Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patients.
Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification.
Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09).
GLUT1 as a Prognostic Factor for Classical Hodgkin's Lymphoma: Correlation with PD-L1 and PD-L2 Expression.
Interim (18)F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine.
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.
Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives.
PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma.
Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology.
Sequential heart and autologous stem cell transplantation for light-chain cardiac amyloidosis.
The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma.
Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma.
A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy.
An isolated cardiac relapse after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia.
Assessment of CD37 B-cell antigen and cell-of-origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Cauda equina lymphoma mimicking non-neoplastic hypertrophic neuropathy of the cauda equina: A case report.
Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.
Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site
MYC mutation profiling and prognostic significance in de novo diffuse large B-cell lymphoma.
Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
Prognostic signifiance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function.
18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement.
A t(8;9)(p22;p24)/PCM1-JAK2 translocation in a patient with myeloproliferative neoplasm and myeloid sarcoma: first report in Korea.
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?
Autophagic Markers BECLIN 1 and LC3 are Associated with Prognosis of Multiple Myeloma.
Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma.
Blastic plasmacytoid dendritic cell neoplasm in the CSF.
Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patients.
Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification.
Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09).
GLUT1 as a Prognostic Factor for Classical Hodgkin's Lymphoma: Correlation with PD-L1 and PD-L2 Expression.
Interim (18)F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine.
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.
Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives.
PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma.
Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology.
Sequential heart and autologous stem cell transplantation for light-chain cardiac amyloidosis.
The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma.
Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma.
A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy.
An isolated cardiac relapse after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia.
Assessment of CD37 B-cell antigen and cell-of-origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Cauda equina lymphoma mimicking non-neoplastic hypertrophic neuropathy of the cauda equina: A case report.
Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.
Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site
MYC mutation profiling and prognostic significance in de novo diffuse large B-cell lymphoma.
Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
Prognostic signifiance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function.
18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement.
A t(8;9)(p22;p24)/PCM1-JAK2 translocation in a patient with myeloproliferative neoplasm and myeloid sarcoma: first report in Korea.
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?
Autophagic Markers BECLIN 1 and LC3 are Associated with Prognosis of Multiple Myeloma.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
The efficacy of systemic high dose methotrexate as central nervous system prophylaxis in patients with high risk diffuse large B-cell lymphoma: A propensity score-matched analysis
A validation study of risk stratification models for diffuse large B-cell lymphoma-not otherwise specified in Korean cohort
A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma-not otherwise specified treated with chemoimmunotherapy
Tissue-compatible EGFR genotyping in tumor-derived extracellular vesicels from malignant pleural effusions
Primary follicular lymphoma of the duodenum: a case report
Expression of immune checkpoint molecule VSIG4 is correlated with poor prognosis in multiple myeloma.
The t(8;9)(p22;p24) Translocation in Myeloproliferative Neoplasm associated with Myeloid Sarcoma
Thiotepa Containing Regimen as Conditioning Chemotherapy for Lymphoma Involving Central Nervous
System Compared With BuCyE (Busulfan, Cyclophosphamide and Etoposide)
A New Prognostic Index for Multiple Myeloma Patients in the Era of Novel Agents.
Splenic rupture in a primary amyloidosis complicated by chronic neutrophilic leukemia: A case study
RGS1 expression in associated with poor prognosis in plasma cell neoplasm
Interim PET-CT as a prognostic tool for predicting clinical outcomes in nodal type T-cell non-Hodgkin lymphoma
Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience
Immunohistochemical Features of Anaplastic Large Cell Lymphoma According to the Anaplastic Lymphoma Kinase (ALK) Positivity and Pattern of Involvement in the Bone Marrow Lesion
A Case of Simultaneous Bone Marrow involvement of Peripheral T cell Lymphoma, NOS in liver and Diffuse Large B cell Lymphoma in stomach
Intravascular large B-cell lymphoma in Korea: Clinical and pathological findings
High-dose chemotherapy and autologous stem-cell transplantation for Korean patients with relapsed or refractory Hodgkin lymphoma
The role of high dose chemotherapy and autologous stem cell transplantation for relapsed T-cell lymphoma
A validation study of risk stratification models for diffuse large B-cell lymphoma-not otherwise specified in Korean cohort
A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma-not otherwise specified treated with chemoimmunotherapy
Tissue-compatible EGFR genotyping in tumor-derived extracellular vesicels from malignant pleural effusions
Primary follicular lymphoma of the duodenum: a case report
Expression of immune checkpoint molecule VSIG4 is correlated with poor prognosis in multiple myeloma.
The t(8;9)(p22;p24) Translocation in Myeloproliferative Neoplasm associated with Myeloid Sarcoma
Thiotepa Containing Regimen as Conditioning Chemotherapy for Lymphoma Involving Central Nervous
System Compared With BuCyE (Busulfan, Cyclophosphamide and Etoposide)
A New Prognostic Index for Multiple Myeloma Patients in the Era of Novel Agents.
Splenic rupture in a primary amyloidosis complicated by chronic neutrophilic leukemia: A case study
RGS1 expression in associated with poor prognosis in plasma cell neoplasm
Interim PET-CT as a prognostic tool for predicting clinical outcomes in nodal type T-cell non-Hodgkin lymphoma
Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience
Immunohistochemical Features of Anaplastic Large Cell Lymphoma According to the Anaplastic Lymphoma Kinase (ALK) Positivity and Pattern of Involvement in the Bone Marrow Lesion
A Case of Simultaneous Bone Marrow involvement of Peripheral T cell Lymphoma, NOS in liver and Diffuse Large B cell Lymphoma in stomach
Intravascular large B-cell lymphoma in Korea: Clinical and pathological findings
High-dose chemotherapy and autologous stem-cell transplantation for Korean patients with relapsed or refractory Hodgkin lymphoma
The role of high dose chemotherapy and autologous stem cell transplantation for relapsed T-cell lymphoma
영상자료
영상자료 내용이 없습니다.
발표자료
원발성 위장관 T세포 림프종의 병리학적 분류에 따른 임상상
A case of Bone marrow involved Histiocytic Sarcoma
A case of Bone marrow involved Histiocytic Sarcoma